Patents by Inventor Anders Dalby

Anders Dalby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDES
    Publication number: 20250333444
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Application
    Filed: November 11, 2024
    Publication date: October 30, 2025
    Inventors: Anders DALBY, Simon Mølgaard JENSEN, Mathias Kaas OLLENDORFF, Kristian STRØMGAARD, Keld FOSGERAU
  • Peptides
    Patent number: 12240921
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Grant
    Filed: May 10, 2024
    Date of Patent: March 4, 2025
    Assignee: Teitur Trophics ApS
    Inventors: Anders Dalby, Simon Mølgaard Jensen, Mathias Kaas Ollendorff, Kristian Strømgaard, Keld Fosgerau
  • NOVEL PEPTIDES
    Publication number: 20240301005
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Application
    Filed: May 10, 2024
    Publication date: September 12, 2024
    Inventors: Anders DALBY, Simon Mølgaard JENSEN, Mathias Kaas OLLENDORFF, Kristian STRØMGAARD, Keld FOSGERAU
  • NOVEL PEPTIDES AND USES THEREOF
    Publication number: 20230312652
    Abstract: The present invention concerns novel cyclic peptides, and medical uses thereof, such as treatment and/or prevention of diseases of the nervous system, neuropathic pain, and/or mental and behavioural disorders, and related aspects.
    Type: Application
    Filed: August 6, 2021
    Publication date: October 5, 2023
    Inventors: Simon Mølgaard Jensen, Simon Glerup Pedersen, Anders Dalby